PROTECT ACCESS AND INNOVATION

Faces of California Biomedical Innovation is a campaign that brings the voices of patients impacted by the biomedical community in California to the forefront. Leading the way, patient voices make it clear that the biomedical sector and the innovative treatments and medtech being developed in it, are essential to a healthier California and world.

Faces of California Biomedical Innovation showcases how people in California are being impacted by life-saving treatments coming out the of the California biomedical industry.

Share Your Story

 

One way to advocate to policymakers in Sacramento and Washington D.C. is for them to hear more stories of how the biomedical community has impacted lives. Share how the biomedical innovation in California has been critical to your wellbeing below. Together, we can continue protecting biomedical innovation in California and around the world.


    Washington knows the importance of offering Medicare Coverage for Innovative Technology (MCIT), preserving hope for thousands of Medicare beneficiaries. We urge DC policymakers to approve MCIT, protecting innovation and patient health. #MCIT https://t.co/uMew6g8zPA

    CLSA - California Life Sciences Association
    CLSA - California Life Sciences Association
    The consideration of foreign price controls brings costly consequences. H.R. 3 would eliminate over 190,000 biotech R&D jobs nationwide and would prevent many new and innovative medicines and treatments from ever coming to market at the expense of patient care and access. Tell Congress we need to preserve patient access and medical innovation in America and reject H.R. 3.

    https://www.statnews.com/2021/04/28/hr3-international-reference-pricing-misses-mark/?fbclid=IwAR381Iq7nsfFh1a_B7x1q3le_rW0KKyI7V1Lo6xbfqDrTG5z9dFavtrMmE0